Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Share-based Compensation (2016 - 2025)

Orthopediatrics has reported Share-based Compensation over the past 10 years, most recently at $4.4 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $4.4 million for Q4 2025, up 13.58% from a year ago — trailing twelve months through Dec 2025 was $17.8 million (up 31.22% YoY), and the annual figure for FY2025 was $17.8 million, up 31.22%.
  • Share-based Compensation for Q4 2025 was $4.4 million at Orthopediatrics, up from $4.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for KIDS hit a ceiling of $5.3 million in Q2 2025 and a floor of $1.3 million in Q1 2021.
  • Median Share-based Compensation over the past 5 years was $2.6 million (2023), compared with a mean of $2.7 million.
  • Biggest five-year swings in Share-based Compensation: tumbled 43.29% in 2021 and later skyrocketed 95.25% in 2023.
  • Orthopediatrics' Share-based Compensation stood at $1.7 million in 2021, then grew by 1.73% to $1.7 million in 2022, then soared by 61.49% to $2.7 million in 2023, then skyrocketed by 41.54% to $3.9 million in 2024, then rose by 13.58% to $4.4 million in 2025.
  • The last three reported values for Share-based Compensation were $4.4 million (Q4 2025), $4.3 million (Q3 2025), and $5.3 million (Q2 2025) per Business Quant data.